Upgrade to SI Premium - Free Trial

Array Biopharma (ARRY) Reaches Agreement with FDA on Phase 3 BEACON CRC SPA

September 14, 2016 7:37 AM
Array BioPharma (Nasdaq: ARRY) announced today that it has reached agreement with the U.S. Food and Drug Administration (FDA) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA

Next Articles